James Parkinson: the man behind the shaking palsy.

  title={James Parkinson: the man behind the shaking palsy.},
  author={Patrick A. Lewis},
  journal={Journal of Parkinson's disease},
  volume={2 3},
  • P. Lewis
  • Published 2012
  • Medicine, Psychology
  • Journal of Parkinson's disease
James Parkinson occupies a unique position in the history of Parkinson's disease. As the man responsible for originally identifying and describing the disease that he called the Shaking Palsy, his name is familiar to anybody with a connection with the disease - patients, carers, clinicians and members of the general public alike. This review summarises the life and career of one of the most recognizable names in neurology. 

Figures from this paper

James Parkinson and his essay on "shaking palsy", two hundred years later.
The authors of this article wish to pay tribute to this great pioneer of neurology, 200 years after the publication of his findings, which would, in turn, immortalize his name and give rise to the renaming on the entity in 1860 by Professor Jean Martin Charcot, father of Neurology.
An update on cellular and molecular determinants of Parkinson's disease with emphasis on the role of the retromer complex
The main aspects of the malfunction of the retromer complex and its implications for PD pathology are reviewed and several controversies still awaiting clarification are highlighted.
Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controls.
Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model
Homologous tissues to hfVM, such as porcine fetal ventral mesencephalon (pfVM) thus present a strong clinical potential if immune response following xenotransplantation could be tamed, and whether Olfactory ensheathing cells (OECs) are glial cells showing immunomodulatory properties can be applied to reducing immune responseFollowing neural xenotranplantation of PD.
Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model
Results are the first to show that CDNF administration enhances the survival of the grafted dopaminergic neurons and improves functional recovery in PD animal model.
Assessment of copper, iron, zinc and manganese status and speciation in patients with Parkinson's disease: A pilot study.


A new look at James Parkinson's Essay on the Shaking Palsy
Commentary on the text of James Parkinson's Essay on the Shaking Palsy identifies important sources of its originality: the particular way in which Parkinson collected and categorized clinical material, his use of a field neurology method to identify affected individuals, and his skills as a narrative writer.
Charcot on Parkinson's disease
  • C. Goetz
  • Psychology, Medicine
    Movement disorders : official journal of the Movement Disorder Society
  • 1986
Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot and he classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time.
The history of Parkinson's disease: early clinical descriptions and neurological therapies.
  • C. Goetz
  • Psychology, Medicine
    Cold Spring Harbor perspectives in medicine
  • 2011
Historically important anatomical, biochemical, and physiological studies identified additional pharmacological and neurosurgical targets for Parkinson's disease and allow modern clinicians to offer an array of therapies aimed at improving function in this still incurable disease.
Parkinson's facies
A fundraising campaign by the Parkinson's Disease Society depicted Dr James Parkinson as a man without a face, for the sound reason that no portrait of him is known to exist.
A Manual of Diseases of the Nervous System
  • W. Gowers
  • Medicine
    Edinburgh Medical Journal
  • 1887
The present work is a most painstaking attempt to systematize and elucidate the vast mass of facts which have been accumulated during the labours of recent years.
Cognitive dysfunction and dementia in Parkinson disease
Clinically, dementia in PD is characterized by uninsidious onset and slowly progressive cognitive decline, with a predominant dysexecutive syndrome accompanied frequently by a variety of behavioral symptoms such as hallucinations, depression, anxiety, and excessive daytime sleepiness.
Lectures on Diseases of the Nervous System
  • M. Charcot's
  • Medicine, Psychology
    Edinburgh Medical Journal
  • 1880
Early descriptions of Parkinson disease in ancient China.
It is concluded that Parkinson disease (PD) was first described more than 2400 years ago in China.
James Parkinson: his life and times
This compilation of essays, although intended to update and complement J. S. Riddell's 1922 history of the Society, makes no attempt to provide either a chronological or thematic account of developments during the two centuries of the Medico-Chirurgical Society's existence.
An Essay on the Shaking Palsy
  • P. James
  • History
    The Medico-Chirurgical Journal and Review
  • 1817
PREFACE The advantages which have been derived from the caution with which hypothetical statements are admitted, are in no instance more obvious than in those sciences which more particularly belong